Iodoxamic acid
![]() | |
Clinical data | |
---|---|
Trade names | Endobil |
Other names | 3-[3-[2-[2-[2-[3-[(3-Carboxy-2,4,6-triiodophenyl)amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.045.875 |
Chemical and physical data | |
Formula | C26H26I6N2O10 |
Molar mass | 1287.925 g·mol−1 |
3D model (JSmol) | |
|
Iodoxamic acid (trade name Endobil) is an organoiodine compound used as a radiocontrast agent.[1] It features both a high iodine content as well as several hydrophilic groups.
See also
[edit]References
[edit]- ^ Mützel W, Taenzer V, Wolf R (1976). "Biotransformation of ioglycamic acid, iodoxamic acid and iotroxic acid in man". Investigative Radiology. 11 (6): 598–601. doi:10.1097/00004424-197611000-00018. PMID 1036733.